Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Gains from Investment Securities (2016 - 2026)

Harvard Bioscience (HBIO) reported Gains from Investment Securities of $16376.0 for Q1 2026, down 85.11% on a QoQ basis from $110000.0 in Q4 2025.

Harvard Bioscience (HBIO) has 11 years of Gains from Investment Securities data on file, last reported at $16376.0 in Q1 2026.

  • Quarterly Gains from Investment Securities changed N/A year-over-year to $16376.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16376.0 (up 102.21% YoY) and the FY2025 annual result came in at $16378.0, down 80.27% from the prior year.
  • Gains from Investment Securities slipped to $16376.0 in Q1 2026 per HBIO's latest filing, from $110000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $708793.0 in Q2 2025 and bottomed at -$451000.0 in Q4 2023.
  • The 5-year median for Gains from Investment Securities is $84000.0 (2022), against an average of $94554.5.
  • The widest annual swing landed in 2023, when Gains from Investment Securities plunged 551.0%; it then soared 4962.81% in 2025.
  • Tracing HBIO's Gains from Investment Securities over 5 years: stood at $100000.0 in 2022, then sank by 551.0% to -$451000.0 in 2023, then jumped by 30.16% to -$315000.0 in 2024, then surged by 134.92% to $110000.0 in 2025, then plunged by 85.11% to $16376.0 in 2026.
  • Per Business Quant, the three latest HBIO Gains from Investment Securities figures stand at $16376.0 (Q1 2026), $110000.0 (Q4 2025), and $166703.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 16,376.00
Mar 31, 2026 16,376.00
Dec 31, 2025 110,000.00
Dec 31, 2025 110,000.00
Sep 30, 2025 166,703.00
Sep 30, 2025 166,703.00
Jun 30, 2025 708,793.00
Jun 30, 2025 708,793.00
Dec 31, 2024 -315,000.00
Dec 31, 2024 -315,000.00
Sep 30, 2024 14,000.00
Sep 30, 2024 14,000.00
Jun 30, 2024 14,000.00
Jun 30, 2024 14,000.00
Mar 31, 2024 26,000.00
Mar 31, 2024 26,000.00
Dec 31, 2023 -451,000.00
Dec 31, 2023 -451,000.00
Sep 30, 2023 112,000.00
Sep 30, 2023 112,000.00
Jun 30, 2023 54,000.00
Jun 30, 2023 54,000.00
Mar 31, 2023 156,000.00
Mar 31, 2023 156,000.00
Dec 31, 2022 100,000.00
Dec 31, 2022 100,000.00
Sep 30, 2022 232,000.00
Sep 30, 2022 232,000.00
Jun 30, 2022 68,000.00
Jun 30, 2022 68,000.00
Mar 31, 2022 501,000.00
Mar 31, 2022 501,000.00
Dec 31, 2021 -506,000.00
Dec 31, 2021 -506,000.00
Sep 30, 2021 208,000.00
Sep 30, 2021 208,000.00
Jun 30, 2021 69,000.00
Jun 30, 2021 69,000.00
Mar 31, 2021 464,000.00
Mar 31, 2021 464,000.00
Dec 31, 2020 -316,000.00
Dec 31, 2020 -316,000.00
Sep 30, 2020 164,000.00
Sep 30, 2020 164,000.00
Jun 30, 2020 105,000.00
Jun 30, 2020 105,000.00
Mar 31, 2020 162,000.00
Mar 31, 2020 162,000.00
Dec 31, 2019 -396,000.00
Dec 31, 2019 -396,000.00
Sep 30, 2019 68,000.00
Sep 30, 2019 68,000.00
Jun 30, 2019 1,000.00
Jun 30, 2019 1,000.00
Mar 31, 2019 94,000.00
Mar 31, 2019 94,000.00
Dec 31, 2018 145,000.00
Dec 31, 2018 145,000.00
Sep 30, 2018 38,000.00
Sep 30, 2018 38,000.00
Jun 30, 2018 281,000.00
Jun 30, 2018 281,000.00
Mar 31, 2018 -489,000.00
Mar 31, 2018 -489,000.00
Dec 31, 2017 109,000.00
Dec 31, 2017 109,000.00
Sep 30, 2017 100,000.00
Sep 30, 2017 100,000.00
Jun 30, 2017 -529,000.00
Jun 30, 2017 -529,000.00
Mar 31, 2017 333,000.00
Mar 31, 2017 333,000.00
Dec 31, 2016 3.78 Mn
Dec 31, 2016 3.78 Mn